Another investigation demonstrated that hsa-miR-425-5p inactivates the Wnt/β-catenin signaling pathway, consequently reducing the expression of MALAT1 and TUG1 in osteosarcoma, thereby inhibiting tumor progression31. Here, TUG1 is linked to osteosarcoma.